Moberg Pharma: Completed enrollment for the Phase 3 study in the US - Redeye

Redeye is encouraged to learn that Moberg Pharma has completed the enrollment to the Phase 3 study for MOB-015 in North America.

Länk till analysen i sin helhet: https://www.redeye.se/research/946026/moberg-pharma-completed-enrollment-for-the-phase-3-study-in-the-us?utm_source=finwire&utm_medium=RSS